89 related articles for article (PubMed ID: 8597378)
1. Use of control cells to standardize enumeration of CD34+ stem cells.
Roth P; Maples J; Hall J; Dailey T
Ann N Y Acad Sci; 1995 Dec; 770():370-2. PubMed ID: 8597378
[No Abstract] [Full Text] [Related]
2. [Controversies in the determination of CD34].
Orfao A; López-Berges MC; Vidriales B; Ercilla G; Nieto MJ; Caballero MD; San Miguel J
Sangre (Barc); 1997 Apr; 42 Suppl 1():7-9. PubMed ID: 9381309
[No Abstract] [Full Text] [Related]
3. Enumeration of CD34+ hematopoietic stem and progenitor cells.
Sutherland DR; Keeney M; Gratama JW
Curr Protoc Cytom; 2003 Aug; Chapter 6():Unit 6.4. PubMed ID: 18770780
[TBL] [Abstract][Full Text] [Related]
4. Quality assurance issues in CD34 cell enumeration.
Turpen P
Am Clin Lab; 1998 Apr; 17(3):12-4. PubMed ID: 10179698
[No Abstract] [Full Text] [Related]
5. Flow cytometric enumeration and immunophenotyping of hematopoietic stem and progenitor cells.
Gratama JW; Sutherland DR; Keeney M; Papa S
J Biol Regul Homeost Agents; 2001; 15(1):14-22. PubMed ID: 11388740
[TBL] [Abstract][Full Text] [Related]
6. Validation of a single-platform method for hematopoietic CD34+ stem cells enumeration according to accreditation procedure.
Massin F; Huili C; Decot V; Stoltz JF; Bensoussan D; Latger-Cannard V
Biomed Mater Eng; 2015; 25(1 Suppl):27-39. PubMed ID: 25538053
[TBL] [Abstract][Full Text] [Related]
7. Validation of the Nordic flow cytometry standard for CD34+ cell enumeration in blood and autografts: report from the third workshop. Nordic Stem Cell Laboratory Group.
Johnsen HE; Baech J; Nikolajsen K
J Hematother; 1999 Feb; 8(1):15-28. PubMed ID: 10192298
[TBL] [Abstract][Full Text] [Related]
8. Immunophenotype of hematopoietic stem cells from placental/umbilical cord blood after culture.
Pranke P; Hendrikx J; Debnath G; Alespeiti G; Rubinstein P; Nardi N; Visser J
Braz J Med Biol Res; 2005 Dec; 38(12):1775-89. PubMed ID: 16302092
[TBL] [Abstract][Full Text] [Related]
9. Identification of the CD34 enumeration on the day before stem cell harvest that best predicts poor mobilization.
Szwajcer D; Jennings-Coutts A; Giftakis A; Wall DA
Transfusion; 2011 Mar; 51(3):587-90. PubMed ID: 21388392
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric CD34+ stem cell enumeration: lessons from nine years' external quality assessment within the Benelux countries.
Levering WH; Preijers FW; van Wieringen WN; Kraan J; van Beers WA; Sintnicolaas K; van Rhenen DJ; Gratama JW
Cytometry B Clin Cytom; 2007 May; 72(3):178-88. PubMed ID: 17397065
[TBL] [Abstract][Full Text] [Related]
11. Standardization of the CFU-GM assay: Advantages of plating a fixed number of CD34+ cells in collagen gels.
Dobo I; Pineau D; Robillard N; Geneviève F; Piard N; Zandecki M; Hermouet S
J Hematother Stem Cell Res; 2003 Oct; 12(5):543-51. PubMed ID: 14594511
[TBL] [Abstract][Full Text] [Related]
12. Enumeration of CD34+ hematopoietic stem cells for reconstitution following myeloablative therapy.
Roscoe RA; Rybka WB; Winkelstein A; Houston AM; Kiss JE
Cytometry; 1994 May; 16(1):74-9. PubMed ID: 7518378
[TBL] [Abstract][Full Text] [Related]
13. Quantitative expression of adhesion molecules on granulocyte colony-stimulating factor-mobilized peripheral blood, bone marrow, and cord blood CD34+ cells.
Gigant C; Latger-Cannard V; Bensoussan D; Feugier P; Bordigoni P; Stoltz JF
J Hematother Stem Cell Res; 2001 Dec; 10(6):807-14. PubMed ID: 11798507
[TBL] [Abstract][Full Text] [Related]
14. Use of hematopoietic progenitor cell count on the Sysmex XE-2100 for peripheral blood stem cell harvest monitoring.
Letestu R; Marzac C; Audat F; Belhocine R; Tondeur S; Baccini V; Garçon L; Cortivo LD; Perrot JY; Lefrère F; Valensi F; Ajchenbaum-Cymbalista F
Leuk Lymphoma; 2007 Jan; 48(1):89-96. PubMed ID: 17327950
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of commonly used clones and fluorochrome conjugates of monoclonal antibodies for CD34 antigen detection.
Arseniev L; Pickerd N; Goudeva L; Hertenstein B; Ganser A
J Hematother Stem Cell Res; 1999 Oct; 8(5):547-59. PubMed ID: 10791905
[TBL] [Abstract][Full Text] [Related]
16. Post-thaw viable CD34(+) cell count is a valuable predictor of haematopoietic stem cell engraftment in autologous peripheral blood stem cell transplantation.
Lee S; Kim S; Kim H; Baek EJ; Jin H; Kim J; Kim HO
Vox Sang; 2008 Feb; 94(2):146-52. PubMed ID: 18028260
[TBL] [Abstract][Full Text] [Related]
17. A controlled comparison of two different clinical grade devices for CD34+ cell selection of autologous blood stem cell grafts.
Björkstrand B; Sundman-Engberg B; Christensson B; Kumlien G
J Hematother; 1999 Feb; 8(1):75-80. PubMed ID: 10192304
[TBL] [Abstract][Full Text] [Related]
18. More on the appropriate fluorochrome-conjugated CD34 antibody choice for the flow cytometric detection of circulating progenitor cells.
D'Arena G; Carotenuto M
Haematologica; 1998 Jan; 83(1):93-4. PubMed ID: 9542330
[No Abstract] [Full Text] [Related]
19. Effects of CD34+ selection and T cell immunodepletion on cord blood hematopoietic progenitors: relevance to stem cell transplantation.
Laver J; Traycoff CM; Abdel-Mageed A; Gee A; Lee C; Turner C; Srour EF; Abboud M
Exp Hematol; 1995 Dec; 23(14):1492-6. PubMed ID: 8542936
[TBL] [Abstract][Full Text] [Related]
20. The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems.
Roots-Weiss A; Papadimitriou C; Serve H; Hoppe B; Koenigsmann M; Reufi B; Oberberg D; Thiel E; Berdel WE
Bone Marrow Transplant; 1997 Jun; 19(12):1239-46. PubMed ID: 9208119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
